Download Aldosterone-Renin Ratio (ARR)

yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Forensic epidemiology wikipedia , lookup

Adherence (medicine) wikipedia , lookup

Prenatal testing wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

0800 ENDO LAB (36 36 52)
[email protected]
Aldosterone-Renin Ratio (ARR)
Clinical Applications:
In screening hypertensive patients for the presence of possible primary aldosteronism.
Patient Preparation:
The test is best done in the ambulant state between 0800-1000hrs, preferably in the
absence of drugs affecting the renin – aldosterone axis. Preferred drugs (in patients unable
to stop hypotensive therapy) include alphablockers (eg doxazosin, prazosin) or calcium
channel blockers. Other hypotensives (β-blockers, ACE inhibitors or angiotensin II blockers,
diuretics) may affect results (see “Interpretation”). Note that the use of spironolactone or
high dose amiloride (>10 mg daily) within 6 weeks of testing will invalidate the test.
Plasma sodium, potassium and creatinine should be measured along with ARR.
Sample Aliquot Requirements:
Request both Aldosterone and Renin assay.
Test Details:
Reference interval for aldo/renin ratio:
pmol L
nmol L hr
pmol L
nmol L hr
Aldosterone-Renin ratio values exceeding 1000 strongly support the presence of primary
aldosteronism provided plasma aldosterone exceeds 400pmol/L and the patient does not
have chronic renal failure. Patients with hypokalaemia, or receiving ACE inhibitors, Ang II
blockers, diuretics may have false negative results, requiring repeat tests when eukalaemic
or after appropriate change in drug therapy.
NB: Definitive testing (eg saline suppression test, urine aldosterone secretion during high
sodium intake) is usually required to confirm the presence of primary aldosteronism.